cor2ed
engage checkpoint medical linkedin twitter
bg

Somatostatin Receptor Ligand device attribute survey

Somatostatin Receptor Ligand device attribute survey

A survey to identify the key Somatostatin Receptor Ligand (SRL) device attributes that lead to the best injection experience in people living with acromegaly and NET, as well as those caring for them. The surveys have been developed by a Scientific Committee comprising Endocrinologists, Nurses and Patient Advocates from the World Alliance of Pituitary Organizations (WAPO) and the International Neuroendocrine Cancer Alliance (INCA).

We are seeking responses from people living with acromegaly and NET, caregivers, nurses and physicians in Denmark, Norway, Spain and the USA.

The surveys for HCPs and for patients/caregivers are available in English, Spanish, Danish and Norwegian.

temporal

I agree that this educational programme:

 

 

 

The surveys have been developed in partnership with INCA and WAPO.

 

Other programmes of interest